Literature DB >> 9842894

Shedding of the soluble IL-6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells.

S A Jones1, S Horiuchi, D Novick, N Yamamoto, G M Fuller.   

Abstract

The soluble IL-6 receptor (sIL-6R) is generated through either proteolytic shedding of the cognate receptor (PC-sIL-6R), or released as the product of differential mRNA splicing (DS-sIL-6R). Using monocytic THP-1 cells, we demonstrate that both mechanisms are independently regulated, and that each process contributes to sIL-6R production. Shedding of the IL-6R was activated by the Ca2+ ionophore, ionomycin, and inhibited by the TNF-alpha protease inhibitor (TAPI). In contrast, basal sIL-6R release was unaffected by Ca2+ depletion and largely insensitive to TAPI. Moreover, although IL-6R shedding was inactivated by serum starvation, non-stimulated production remained intact. Basal sIL-6R production via differential mRNA splicing was shown through the inhibitory action of brefeldin A and an enzyme-linked immunosorbent assay specific for DS-sIL-6R. Release of this isoform was unaffected by ionomycin or TAPI, indicating that Ca2+ mobilization activates PC-sIL-6R generation, but not DS-sIL-6R. The divergent control of these sIL-6R isoforms indicates that they may independently influence the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842894     DOI: 10.1002/(SICI)1521-4141(199811)28:11<3514::AID-IMMU3514>3.0.CO;2-T

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

Authors:  Simon A Jones; Jürgen Scheller; Stefan Rose-John
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

2.  Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst.

Authors:  Jun Wang; Qing Wang; Tao Han; Yong-Kui Li; Sheng-Li Zhu; Fang Ao; Jian Feng; Ming-Zhen Jing; Li Wang; Lin-Bai Ye; Ying Zhu
Journal:  Cell Mol Immunol       Date:  2014-09-01       Impact factor: 11.530

3.  Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.

Authors:  Christoph Garbers; Nathalie Jänner; Athena Chalaris; Marcia L Moss; Doreen M Floss; Dörte Meyer; Friedrich Koch-Nolte; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2011-03-15       Impact factor: 5.157

4.  Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells.

Authors:  W Thabard; M Collette; R Bataille; M Amiot
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

5.  High habitual dietary alpha-linolenic acid intake is associated with decreased plasma soluble interleukin-6 receptor concentrations in male twins.

Authors:  Jun Dai; Thomas R Ziegler; Roberd M Bostick; Amita K Manatunga; Dean P Jones; Jack Goldberg; Andrew Miller; Gerald Vogt; Peter W Wilson; Linda Jones; Lucy Shallenberger; Viola Vaccarino
Journal:  Am J Clin Nutr       Date:  2010-05-12       Impact factor: 7.045

6.  Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.

Authors:  N J Van Wagoner; J W Oh; P Repovic; E N Benveniste
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

7.  Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.

Authors:  Thanh-Thuy T Le; Harry Karmouty-Quintana; Ernestina Melicoff; Thanh-Truc T Le; Tingting Weng; Ning-Yuan Chen; Mesias Pedroza; Yang Zhou; Jonathan Davies; Kemly Philip; Jose Molina; Fayong Luo; Anuh T George; Luis J Garcia-Morales; Raquel R Bunge; Brian A Bruckner; Matthias Loebe; Harish Seethamraju; Sandeep K Agarwal; Michael R Blackburn
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

8.  Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells.

Authors:  Eva M Briso; Oliver Dienz; Mercedes Rincon
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease.

Authors:  Miriam Cortez-Cooper; Eric Meaders; Judith Stallings; Sara Haddow; Barbara Kraj; Gloria Sloan; Kevin K McCully; Joseph G Cannon
Journal:  Vasc Med       Date:  2013-10       Impact factor: 3.239

10.  Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.

Authors:  Janina Wolf; Georg H Waetzig; Athena Chalaris; Torsten M Reinheimer; Henning Wege; Stefan Rose-John; Christoph Garbers
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.